ChromaDex (CDXC) Spike Over 7% as Traders Circulate Comments from Roth/MKM, 'unwarranted price weakness as a buying opportunity'
Tweet Send to a Friend
Roth/MKM analyst Sean McGowan reiterated a Buy rating and $8.00 price target on ChromaDex (NASDAQ: CDXC).The analyst comments "Yesterday (12/04) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
